HealthEquity Inc 2026年季度报告

Form 10-Q ☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2026OR☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934Commission file number: 001-36568 HEALTHEQUITY, INC. (Exact name of registrant as specified in its charter) 52-2383166(I.R.S. EmployerIdentification Number) Delaware 15 West Scenic Pointe DriveSuite 100Draper, Utah 84020(Address of principal executive offices) (Zip code) (801)727-1000(Registrant's telephone Number, including Area Code) Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d) of the Securities Exchange Act of 1934during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)has been subject to such filingrequirements for the past 90 days. Yes☑No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit suchfiles).Yes☑No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or anemerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growthcompany" in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any newor revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the ExchangeAct). Yes☐No☑ As of May20, 2026, there were 83,602,157 shares of the registrant's common stock outstanding. HealthEquity, Inc. and subsidiariesForm 10-Q quarterly report Table of contents Part I. FINANCIAL INFORMATIONItem 1.Financial statementsCondensed consolidated balance sheets as of April 30, 2026 (unaudited) and January 31, 2026Condensed consolidated statements of operations for the three months ended April 30, 2026 and 2025 (unaudited)Condensed consolidated statements of comprehensive income for the three months ended April 30, 2026 and2025 (unaudited)Condensed consolidated statements of stockholders' equity for the three months ended April 30, 2026 and 2025(unaudited)Condensed consolidated statements of cash flows for the three months ended April 30, 2026 and 2025 (unaudited)Notes to condensed consolidated financial statements (unaudited)Item 2.Management's discussion and analysis of financial condition and results of operationsItem 3.Quantitative and qualitative disclosures about market riskItem 4.Controls and proceduresPart II. OTHER INFORMATIONItem 1.Legal proceedingsItem 1A.Risk factorsItem 5.Other informationItem 6.ExhibitsSignatures HealthEquity, Inc. and subsidiariesCondensed consolidated balance sheets HealthEquity, Inc. and subsidiariesNotes to condensed consolidated financial statements (unaudited) Note1.Summary of business and significant accounting policies Business HealthEquity, Inc. ("HealthEquity" or the "Company") was incorporated in the state of Delaware on September18, 2002.HealthEquity is a leader in administering health savings accounts (“HSAs”) and complementary consumer-directedbenefits (“CDBs”), which empower consumers to access tax-advantaged healthcare savings while also providingcorporate tax advantages for employers. Principles of consolidation The Company consolidates entities in which the Company has a controlling financial interest, which includes all of itswholly owned direct and indirect subsidiaries. All significant intercompany accounts and transactions have been eliminatedin consolidation. Segments The Company is managed as a single operating segment that provides administration services in connection with HSAsand other CDBs, which reflects the way in which its chief operating decision maker (“CODM”), the Chief Executive Officer,reviews the Company's financial performance and makes decisions about resource allocation. The CODM assesses theperformance of the Company, monitors actual financial results against budgets, and makes resource allocation decisionswith a focus on the Company’s consolidated results as presented in the condensed consolidated statements of operations.The Company’s measure of profitability is net income. Single segment-level financial information, including total assets,significant non-cash transactions, and capital expenditures, is contained in the accompanying condensed consolidatedfinancial statements and related notes. The Company does not generate international revenues. All long-lived assets are maintained in the U